Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Bone scintigraphy in plasma cell myeloma

  • 16 Accesses

  • 1 Citations


A retrospective study of histologically proven cases of plasma cell myeloma during a 13-year period showed that bone scintigraphy was performed in 15 patients. With respect to radiologically shown areas of bone destruction, scanning revealed an increased (44%), normal (48%), or decreased (8%) radionuclide uptake. Abnormal scintigraphic findings were predominantly found in the axial parts of the skeleton. Abnormal isotope accumulations in the ossei occurred more often than normal uptake in symptomatic patients.

This is a preview of subscription content, log in to check access.


  1. 1.

    Bataille R, Chevalier J, Rossi M, Sany J (1982) Bone scintigraphy in plasma-cell myeloma, a prospective study of 70 patients. Radiology 145: 801–804

  2. 2.

    Frank JW, Lebesque S, Buchanan RB (1982) The value of bone imaging in multiple myeloma. Eur J Nucl Med 7: 502–505

  3. 3.

    Koizumi K, Tonami N, Hisada K (1978) 99mTc-Diphosphonate bone scanning in 10 patients with multiple myeloma. Jpn J Nucl Med 15: 554–559

  4. 4.

    Wahner HW, Kyle RA, Beabout JW (1980) Scintigraphic evaluation of the skeleton in multiple myeloma. Mayo Cl Proc 55: 739–746

  5. 5.

    Waxman AD, Siemsen JK, Levine AM, Holdorf D, Suzuki R, Singer FR, Bateman J (1981) Radiographic and radionuclide imaging in multiple myeloma: the role of gallium scintigraphy: concise communication. J Nucl Med 22: 232–236

Download references

Author information

Correspondence to F. L. Ampil.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ampil, F.L., Mills, G.M. Bone scintigraphy in plasma cell myeloma. Eur J Orthop Surg Traumatol 9, 59–60 (1999). https://doi.org/10.1007/BF01695724

Download citation

Key words

  • Myeloma
  • Bone scan